Bioextrax AB (85X0) Stock Statistics & Valuation Metrics

Bioextrax AB has a market cap or net worth of €8.10M. The enterprise value is €116.59M.

Bioextrax AB has 39,123,074 shares outstanding. The number of shares has decreased by -2.65% in one year.

Bioextrax AB’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Bioextrax AB is -7.00. Bioextrax AB’s PEG ratio is 0.20.

In the last 12 months, Bioextrax AB had revenue of 515.00K and earned -17.34M in profits. Earnings per share was -0.52.

In the last 12 months, operating cash flow was -18.78M and capital expenditures -215.00K, giving a free cash flow of -18.99M billion.

Bioextrax AB pays an annual dividend of ―, resulting in a dividend yield of ―

Bioextrax AB upcoming earnings date is May 15, 2025, TBA Not Confirmed.

Bioextrax AB as a current ratio of 6.54, with Debt / Equity ratio of 0.00%

In the past 12 months, Bioextrax AB has paid 0.00 in taxes.

Bioextrax AB EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Bioextrax AB has €17.27M in cash and marketable securities with kr0.00 in debt, giving a net cash position of -€17.27M billion.

Gross margin is -163.88%, with operating margin of -3405.63%, and net profit margin of -3366.60%.

The average price target for Bioextrax AB is ―, which is 11.43% higher than the current price. The consensus rating is ―